A Prospective, Multi-Center, Single-Dose, Phase 1 Clinical Trial Designed to Evaluate the Pharmacokinetics of Dexamethasone Phosphate Ophthalmic Solution Delivered Via the EyeGate® II Drug Delivery System in Patients Undergoing Vitrectomy for Macular Hole Repair or Epiretinal Membrane Peeling
Phase of Trial: Phase I
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Dexamethasone (Primary)
- Indications Eye disorders
- Focus Pharmacokinetics
- Sponsors EyeGate Pharma
- 06 Feb 2017 Status changed from recruiting to completed.
- 03 May 2016 Planned End Date changed from 1 Jun 2016 to 1 Nov 2016.
- 03 May 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Oct 2016.